16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Application of desirability-based multi(bi)-objective optimization in the design of selective arylpiperazine derivates for the 5-HT1A serotonin receptor.

University of Porto
Boosting caffeic acid performance as antioxidant and monoamine oxidase B/catechol-O-methyltransferase inhibitor.

University of Porto
Design and synthesis of chromone-based monoamine oxidase B inhibitors with improved drug-like properties.

University of Porto
Bis-chalcones: A review of synthetic methodologies and anti-inflammatory effects.

University of Porto
Discovery of New Potent Positive Allosteric Modulators of Dopamine D

University of Porto
Development of potent CPP6-gemcitabine conjugates against human prostate cancer cell line (PC-3).

University of Porto
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.

University of Porto
Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors.

University of Porto
Development of Blood-Brain Barrier Permeable Nitrocatechol-Based Catechol O-Methyltransferase Inhibitors with Reduced Potential for Hepatotoxicity.

University of Porto
Benzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and neuroprotective agents.

University of Porto
Structure-Based Optimization of Coumarin hA

University of Porto
Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: Structure-activity-toxicity, drug-likeness and efflux transport studies.

University of Porto
Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.

University of Porto
Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis.

University of Porto
Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?

University of Porto
Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances.

University of Porto